VITROS CHEMISTRY PRODUCTS VALP REAGENT 6801710

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2018-10-24 for VITROS CHEMISTRY PRODUCTS VALP REAGENT 6801710 manufactured by Ortho-clinical Diagnostics.

Event Text Entries

[126369054] The investigation determined that lower than expected valproic acid results were obtained from patient samples processed as part of a valp lot to lot correlation using a vitros 5600 integrated system. The most likely assignable cause is a combination of vitros valp lot to lot variability and pre-analytical sample handling. The customer indicated the specimens were tested days beyond original collection date, poured off multiple times, and subjected to multiple refrigeration/ambient temperature cycles. This type of specimen is not representative of normal handling for routine patient specimens and/or correlation specimens. Therefore, it is concluded that the pre-analytical sample handling is a likely contributor to this event. There was no indication of a performance issue with the vitros valp lots (2511-25-6393 and 2511-26-6711) used in the patient correlation based on qc performance; however, the vitros valp lot 2511-25-6393 accuracy was lower than valp lot 2511-26-6711 as shown with the patient correlation results. The vitros valp lot 2511-26-6711 performance was set to the reference method and therefore, the results from that lot were considered the expected results for this correlation data set. It was confirmed by ortho that both vitros valp lots have performed within ortho release guidelines. In addition, the customer indicated that any shift in patient data seen was not considered to be clinically significant at the time.
Patient Sequence No: 1, Text Type: N, H10


[126369055] A customer obtained lower than expected valproic acid results from patient samples using a vitros 5600 integrated system in combination with vitros valp reagent. Sample 21 = 41. 4 versus expected 51. 8 ug/ml, sample 23 = 40. 3 versus expected 52. 3 ug/ml. Biased results of the magnitude and direction observed may lead to inappropriate physician action if they were to occur undetected. The patient sample results in question were obtained as part of a vitros valp lot to lot correlation study and therefore, no patient results were reported outside the laboratory. There was no allegation of patient harm. This report corresponds to ortho clinical diagnostics inc. Complaint numbers: (b)(4).
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1319808-2018-00042
MDR Report Key7998594
Date Received2018-10-24
Date of Report2019-01-04
Date of Event2018-09-21
Date Mfgr Received2018-09-27
Device Manufacturer Date2017-10-05
Date Added to Maude2018-10-24
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. JAMES A STEVENS
Manufacturer Street100 INDIGO CREEK DRIVE
Manufacturer CityROCHESTER NY 14626
Manufacturer CountryUS
Manufacturer Postal14626
Manufacturer Phone5854533000
Manufacturer G1ORTHO-CLINICAL DIAGNOSTICS
Manufacturer Street1000 LEE ROAD
Manufacturer CityROCHESTER NY 14606
Manufacturer CountryUS
Manufacturer Postal Code14606
Single Use3
Previous Use Code3
Event Type3
Type of Report0

Device Details

Brand NameVITROS CHEMISTRY PRODUCTS VALP REAGENT
Generic NameIN VITRO DIAGNOSTICS
Product CodeLEG
Date Received2018-10-24
Catalog Number6801710
Lot Number2511-25-6393
Device Expiration Date2019-04-04
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerORTHO-CLINICAL DIAGNOSTICS
Manufacturer Address100 INDIGO CREEK DRIVE ROCHESTER NY 14626 US 14626


Patients

Patient NumberTreatmentOutcomeDate
10 2018-10-24

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.